Rivaroxaban Cuts Stroke Risk in HF Sans AF: Post Hoc COMMANDER-HF

Oral anticoagulation may have struck the right balance between stroke benefit and bleeding risk in systolic heart failure. Also, a stroke risk prediction tool may be more versatile than expected.
Medscape Medical News

Source link

Related posts

Novel Anti-B-Cell Therapy Looks Promising in MS


clinical neurology; +111 new citations


Myoclonic-Atonic Seizures and Lennox-Gastaut Syndrome Present With Overlapping Features, Difficulty in Diagnosis


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy